1280768

CLSI M23A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

standard by Clinical and Laboratory Standards Institute , 05/01/2001

Mary Jane Ferraro, Ph.D., M.P.H.

This document has been replaced. View the most recent version.

View all product details

Historical

Track It

This item is not available for sale.

Customers Who Bought This Also Bought

 

About This Item

 

Full Description

CLSI M23A2 addresses the required and recommended data needed for the selection of appropriate interpretive standards and quality control guidelines for antimicrobial agents.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

 

Product Details

Edition:
Second Edition
Published:
05/01/2001
ISBN(s):
156238435X
Number of Pages:
28
 

Document History

  1. CLSI M23-Ed5


    Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters, 5th Edition, M23Ed5E

    • Most Recent

  2. CLSI M23-Ed4


    Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; 4th Edition M23Ed4E

    • Historical Version

  3. CLSI M23-A3


    Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline--Third Edition, M23A3E

    • Historical Version

  4. CLSI M23A2

    👀 currently
    viewing


    Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

    • Historical Version